Literature DB >> 4812960

The influence of diphenylhydantoin on primidone metabolism.

R W Fincham, D D Schottelius, A L Sahs.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812960     DOI: 10.1001/archneur.1974.00490330067012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  10 in total

1.  Interaction of phenytoin and primidone.

Authors:  E H Reynolds; G Fenton; P Fenwick; A L Johnson; M Laundy
Journal:  Br Med J       Date:  1975-06-14

Review 2.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 3.  Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Authors:  R Riva; F Albani; M Contin; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

Review 4.  Drug interactions with phenytoin.

Authors:  E Perucca; A Richens
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

5.  The effect of phenytoin and ethosuximide on primidone metabolism in patients with epilepsy.

Authors:  D Schmidt
Journal:  J Neurol       Date:  1975-06-09       Impact factor: 4.849

Review 6.  Interactions with antiepileptic drugs.

Authors:  A Richens
Journal:  Drugs       Date:  1977-04       Impact factor: 9.546

Review 7.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

8.  Phenytoin: an inhibitor and inducer of primidone metabolism in an epileptic patient.

Authors:  M G Porro; H J Kupferberg; R J Porter; W H Theodore; M E Newmark
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

9.  The effects of phenytoin on phenobarbitone and primidone metabolism.

Authors:  D G Lambie; R H Johnson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

Review 10.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.